News & Analysis on Clinical Trial Services & Contract Research And Development
BioAscent Discovery Limited
By Melissa Fassbender
- Last updated on
BioAscent Discovery Limited has appointed Paul Smith as CEO ahead of the company’s plans to expand its discovery service offering.
Smith was previously CEO of CXR Biosciences, a preclinical CRO that is now part of Concept Life Sciences Group.
“The pharma industry continues to outsource more and more areas of drug discovery and BioAscent has the dedicated facility, personnel, and experience to provide increased value to our customers in early discovery chemistry and biology,” Smith said in the company’s press release.
“Our Newhouse facility already offers unparalleled infrastructure for managing solid and liquid compounds and I’m really looking forward to working with the great team here at BioAscent to build a more complete range of discovery services.”